#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Amyotrophic lateral sclerosis gene carrier Myxoid liposarcoma Prophylaxis against transplant rejection Still's disease Thromboangiitis obliterans Pleural mesothelioma malignant Cytokine release syndrome Thrombocytopenia Rectal cancer Colitis ulcerative Anal cancer recurrent Piriformis syndrome Fibrous dysplasia of bone Multiple system atrophy Congenital leptin deficiency More trials…

    Learn about Rare Diseases

    Mast cell activation syndrome – Diagnostics MELAS syndrome – Trials in Disease Vascular malformation – Treatment Primary immunodeficiency syndrome – Basic Information IgA nephropathy – Life with Disease Mast cell activation syndrome – Basic Information Noonan syndrome Encephalitis autoimmune – Treatment Hepatic angiosarcoma – Life with Disease SAPHO syndrome – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    TEDUGLUTIDE Itepekimab TIFCEMALIMAB Pabinafusp Alfa Decitabine Levothyroxine Lanifibranor A3907 SARACATINIB Pemetrexed Azithromycin Dihydrate Wt1 Mrna Dc Alectinib Quavonlimab Anastrozole Metamizole Sodium Monohydrate HYDROGEN Allo-501A Eight Treg Tarlatamab More therapies…

    Learn about Your Condition

    Guttate psoriasis Testicular leiomyosarcoma Urethral stenosis Epileptic encephalopathy Mental disorder Metastatic neoplasm Ehlers-Danlos syndrome Ischaemic stroke Breast cancer female Subarachnoid haemorrhage Hypersensitivity Iron deficiency anaemia Neuropathy peripheral Pneumothorax SAPHO syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. IRCCS Humanitas Research Hospital

IRCCS Humanitas Research Hospital

Via Alessandro Manzoni 56, Rozzano, 20089, Italy

Want to learn more about this study or check if you can participate? Contact us.

  • Study Comparing FOLFIRI with Cetuximab or Bevacizumab for First-Line Treatment in Patients with Metastatic Colorectal Cancer and Specific Genetic Profiles

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Calcium Folinate
    • Bevacizumab
    • Cetuximab
    Italy

  • Study on Pembrolizumab and Radiotherapy for Patients with Limited Spread of Head and Neck Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Squamous cell carcinoma of head and neck
    Investigated Drugs:
    • Pembrolizumab
    Belgium Italy Spain

  • Study on the Use of Landiolol Hydrochloride and Sodium Chloride for Patients Undergoing Mitral Valve Surgery to Prevent Low-Cardiac Output Syndrome

    Recruiting

    3 1 1
    Investigated Drugs:
    • Landiolol Hydrochloride
    • Sodium Chloride
    Italy

  • Study on Zanidatamab and Chemotherapy for Patients with Metastatic HER2-Positive Breast Cancer After Trastuzumab Deruxtecan Treatment

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Breast cancer
    • Breast cancer metastatic
    Investigated Drugs:
    • Eribulin Mesylate
    • Capecitabine
    • Gemcitabine Hydrochloride
    Austria Belgium France Germany Greece Italy +2

  • Study of drug combination with gemcitabine, cisplatin, carboplatin and avelumab in patients with advanced urothelial cancer to evaluate response to platinum-based chemotherapy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Transitional cell carcinoma
    Investigated Drugs:
    • Avelumab
    • Carboplatin
    • Cisplatin
    Italy

  • Study on Apixaban and Edoxaban for Preventing Stroke in Patients with Recent Perioperative Atrial Fibrillation After Noncardiac Surgery

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Apixaban
    • Dabigatran
    • Rivaroxaban
    Belgium Denmark Finland France Germany Greece +5

  • Study on the Effects of Oseltamivir and Drug Combination for Patients with Pneumonia

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Oseltamivir
    • Baloxavir Marboxil
    • Dexamethasone Ph. Eur.
    Belgium Estonia France Italy The Netherlands Portugal +3

  • Study on the Effects of ZN-c3 for Patients with High-Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Azenosertib
    • Betamethasone Sodium Phosphate Ph. Eur
    • Granisetron
    Belgium France Italy Poland Spain

  • Long-Term Follow-Up Study for Patients Treated with CAR T-Cell Therapy Using PHE885, YTB323, and Tisagenlecleucel

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • B-cell type acute leukaemia
    • B-cell lymphoma
    • Plasma cell myeloma
    Investigated Drugs:
    • Autologous T-Cells Encoding A Chimeric Antigen Receptor Targeting Human B Cell Maturation Antigen
    • Tisagenlecleucel
    • Rapcabtagene Autoleucel
    Austria Belgium Denmark Finland France Germany +6

  • Study on Lomustine with or without Additional Brain Radiation for Patients with Recurrent Glioblastoma

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Glioblastoma
    Austria Belgium Czechia Denmark France Germany +4
Previous Page
1 … 20 21 22 23 24 … 69
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!